期刊文献+

急性早幼粒细胞白血病治疗前血象与预后分析 被引量:3

Analysis of the Pretreatment Hemogram Changes and Its Relation to Prognosis of Patients With Acute Promyelocytic Leukemia
下载PDF
导出
摘要 目的:探讨急性早幼粒细胞白血病(APL)患者治疗前外周血白细胞计数变化规律与预后的关系。方法:总结12例首诊时被误诊为其他疾病(或急性白血病的其他类型),最后在我科确诊为APL的患者首诊及确诊时血象、凝血功能变化及转归。结果:首诊至确诊为APL的时间4~45d不等,平均13.4d。9例确诊时WBC计数较首诊时升高,3例下降。首诊和确诊时平均WBC计数分别为5.13×10^9/L、25.16×10^9/L。经治疗后5例死亡,均在诱导治疗期间死于颅内出血,其余7例至今均为持续完全缓解(CCR)状态。结论:APL发病早期,患者外周血WBC计数多低于正常,以后,WBC计数可逐渐升高,凝血功能紊乱及出血倾向亦渐加重,患者的预后也明显变差。 Objective:To explore the changes of WBC count of peripheral blood in patients with acute promyelo cytic leukemia (APL) before treatment and its correlation with prognosis. Methods: All the data of the misdiagnosed patients who were confirmed as APL afterwards in our hospital were collected for a retrospective study. Re suits: The time from first visit to final diagnosis as APL was 4 to 45 days, with average of 13.4 days. WBC counts in 9 cases was higher at the time of diagnose as APL than that at first visit, while 3 was lower at the time of confirmation as APL. The average WBC counts of patients at the time of first visit and confirmation of diagnosis as APL was 5. 13×10^9/L and 25.16×10^9/L respectively. Five of the cases died of intracranial hemorrhage during induction therapy, the others had been in continuous complete remission (CCR) so far. Conclusion: WINg count was lower than normal values in the early stage of APL. With the delay of diagnosis, the WBC count becomes higher, the impaired coagulation function more prominant, and the prognosis of the patients get worse obviously.
出处 《内科急危重症杂志》 2008年第5期252-254,共3页 Journal of Critical Care In Internal Medicine
关键词 急性早幼粒细胞 白血病 白细胞预后 Acute promyelocytic leukemia White blood cell Prognosis
  • 相关文献

参考文献4

  • 1Tallmann MS. Curative therapeutic approaches to APL. Ann Hematol, 2004, 83 Suppl 1 : S81.
  • 2Burnett AK, Grimwade D, Solomon E, et al. Presenting white blood cell count and kinetics of molecular remission predict prognosis in acute promyelocytic leukemia treated with all-trans retinoic acid: result of the Randomized MRC Trial. Blood, 1999, 93: 4131.
  • 3Chou WC, Tang JL, Yao M, et al. Clinical and biological characteristics of acute promyelocytic leukemia in Taiwan: a high relapse rate in patients with high initial and peak white blood cell counts during all trans retinoic acid treatment. Leukemia, 1997,11: 921.
  • 4Sanz MA, Lo Coco F, Martin G, et al. Definition of relapse risk and role of nonanthracycline drugs for consolidation in patients with acute promyelocytic leukemia: a joint study of the PETHEMA and GIMEMA cooperative groups. Blood, 2000,96: 1247.

同被引文献5

引证文献3

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部